Business
DBP.B: Equity restored and net loss reduced as SI-053 development progressed, but funding needs persist
DBP.B: Equity restored and net loss reduced as SI-053 development progressed, but funding needs persist
About this update from Double Bond Pharmaceutical International Ab Class B
Development of SI-053 advanced, with SEK 11.85 million raised through share issues, restoring equity and supporting operations. Net loss narrowed to SEK -333,000, and the equity ratio improved to 74.9%. Ongoing need for external financing remains.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
View stock analysis, news, and events for Double Bond Pharmaceutical International Ab Class B